51 52 Routine full characterization of Mycobacterium tuberculosis (TB) is culture--53 based, taking many weeks. Whole--genome sequencing (WGS) can generate 54 antibiotic susceptibility profiles to inform treatment, augmented with strain 55 information for global surveillance; such data could be transformative if 56 provided at or near point of care. 57 58 We demonstrate a low--cost DNA extraction method for TB WGS direct from 59 patient samples. We initially evaluated the method using the Illumina MiSeq 60 sequencer (40 smear--positive respiratory samples, obtained after routine clinical 61 testing, and 27 matched liquid cultures). M. tuberculosis was identified in all 39 62 samples from which DNA was successfully extracted. Sufficient data for 63 antibiotic susceptibility prediction was obtained from 24 (62%) samples; all 64 results were concordant with reference laboratory phenotypes. Phylogenetic 65 placement was concordant between direct and cultured samples. Using an 66 Illumina MiSeq/MiniSeq the workflow from patient sample to results can be 67 completed in 44/16 hours at a cost of £96/£198 per sample. 68 69 We then employed a non--specific PCR--based library preparation method for 70 sequencing on an Oxford Nanopore Technologies MinION sequencer. We applied 71 this to cultured Mycobacterium bovis BCG strain (BCG), and to combined culture--72 negative sputum DNA and BCG DNA. For the latest flowcell, the estimated 73 turnaround time from patient to identification of BCG was 6 hours, with full 74 susceptibility and surveillance results 2 hours later. Antibiotic susceptibility 75 predictions were fully concordant. A critical advantage of the MinION is the 76 ability to continue sequencing until sufficient coverage is obtained, providing a 77 potential solution to the problem of variable amounts of M. tuberculosis in direct 78 samples. 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 3
The long--standing gold standard for Mycobacterium tuberculosis drug 100 susceptibility testing (DST) is the phenotypic culture--based approach, which is 101 time--consuming and laborious. First--line tuberculosis (TB) treatment includes 102 four drugs (rifampicin, isoniazid, ethambutol and pyrazinamide) but with the 103 spread of multi--drug resistant strains, there is a growing need for data on 104 second--line drugs, including the fluoroquinolones, and aminoglycosides.
tuberculosis DNA prior to WGS. 20/24 smear--positive samples achieved 90% 147 genome coverage with ≥20x depth; sufficient for prediction of species and 148 antibiotic susceptibility. However, the protocol was slow (2--3 days) and may be 149 prohibitively expensive for use in low--income settings. 150 151
In this study we test a simple low--cost DNA extraction method using Illumina 152
MiSeq WGS on 40 smear--positive, primary respiratory samples from M. 153 tuberculosis infected patients. We evaluate the protocol in terms of DNA 154 obtained, species assignment of the sequenced reads, and our ability to obtain 155 key clinical data (detection of M. tuberculosis and antibiotic susceptibility 156 prediction) along with epidemiological information (placement on phylogenetic 157 tree). These data would enable a single test to deliver the core information for 158 both patient and public health in <48 hours using Illumina--based WGS. We also 159 develop an approach for WGS using the highly portable, random--access, Oxford 160 Nanopore Technologies (ONT) MinION, reducing potential turnaround time to 8 All MinION sequencing utilized the best sample preparation kits and flow cells 231 available at the time. A single ZN--negative sputum extract was divided into three 232 equal concentration aliquots (187 ng), and BCG DNA added at 5%, 10% and 15% 233 of the total sputum DNA concentration. These 5--15% spikes represent the lower 234 end of the spectrum seen in the MiSeq samples above (see Figure 2a ). These 235 samples, along with pure BCG DNA, were prepared following ONTs PCR--based 236 protocol for low--input libraries (DP006_revB_14Aug2015), using modified 237 primers supplied by ONT, a 20 ng DNA input into the PCR reaction, and LongAmp 238
Taq 2X Master Mix (New England Biolabs, USA). PCR conditions were as follows: 239 initial denaturation at 95°C for 3 minutes, followed by 18 cycles of 95°C for 15s, 240 62°C for 15s, and 65°C for 2.5 minutes, and a final extension at 65°C for 5 241 minutes. Samples were cleaned in 0.4x volume AMPure beads and the PCR 242 product assessed using the Qubit fluorimeter and TapeStation (Agilent, UK). The 243 final elution was into 10 µL 50 mM NaCl, 10 mM Tris.HCl pH8.0. Finally, 1 µL of 244 PCR--Rapid Adapter (PCR--RAD; supplied by ONT) was added and samples 245 incubated for 5 minutes at room temperature to generate pre--sequencing mix. 246
The pre--sequencing mix was prepared for loading onto flow cells following 247 standard ONT protocols, with a loading concentration of 50 -100 fmol. 248 249
Using the 15% BCG spiked sputum DNA prepared above, amplification was 250 repeated using Phusion High--Fidelity PCR Master Mix with DMSO (New England 251
BioLabs, USA). Gradient PCR was performed to identify the optimal annealing 252 temperature for recovery of BCG DNA (data not shown). Final PCR conditions 253 were as follows: initial denaturation at 98°C for 30s, followed by 18 cycles of 254 98°C for 10s, 59°C for 15s, and 72°C for 1.5 minutes, and a final extension of 72°C 255 for 10 minutes. Following PCR, the sample was prepared for sequencing as 256 described above. The final loading concentration was approximately 27 fmol. 257 258
The above samples were sequenced using R9 spot--on generation flow cells and 259 the 48--hour protocol for FLO--MIN105 (ONT, UK). Base calling was performed via 260
the Metrichor EPI2ME service (ONT, UK) using the 1D RNN for SQK--RAD001 261 v1.107 workflow. 262 263
Subsequently, a new 15% BCG spiked sputum was prepared as described above 264
using Phusion Master Mix with DMSO. Sequencing was performed using R9.4 265 spot--on generation flow cells and the 48--hour FLO--MIN106 protocol (ONT, UK). 266
Final loading concentration was 43 fmol. Base calling was performed after 267 sequencing was complete using Albacore (ONT, UK), as base calling via Metrichor 268
failed .  269   270   271   272   273 Bioinformatic analysis of Illumina data 274
To determine levels of contamination and M. tuberculosis in samples, reads were 275 immediately mapped using bwa_mem (20) to the human reference genome 276
GRCh37 (hg19) and human reads counted and permanently discarded. 277
Remaining stored reads where then mapped to the M. tuberculosis H37Rv 278 reference strain (GenBank NC_018143.2), and any unmapped reads were then 279 mapped to nasal, oral and mouth flora available in the NIH Human Microbiome 280
Project database (http://www.hmpdacc.org/). A minimum reference genome 281 coverage depth of 5 was required for phylogenetic analysis to proceed. 282 283
Mycobacterial species and antibiotic resistance to isoniazid, rifampicin, 284 ethambutol, pyrazinamide, streptomycin, aminoglycosides (including 285 capreomycin, amikacin and kanamycin) and fluoroquinolones (including 286 moxifloxacin, ofloxacin, and ciprofloxacin) was predicted using Mykrobe 287 predictor software (21) v0.3.5 updated with a new validated catalogue of 288 resistance conferring genetic mutations (1) . For samples where the estimated 289 depth of kmer--coverage of M. tuberculosis reported by Mykrobe predictor fell 290 below 3x, no resistance predictions were made. The precise command used 291 was:,``mykrobe predict SAMPLE_ID tb --1 FASTQ -panel walker--2015 -min--depth 292 3". 293 294 295
Phylogenetic analysis 296
Conservative SNP calls were made using Cortex (22) (independent workflow, 297 k=31) on 3480 samples from (1). Singleton variants were discarded, and a de--298 duplicated list of 68695 SNPs was constructed. All samples (from our study and 299
from (1)) were genotyped at these sites using the Cortex genotyping model (22). 300 We then measured the number of SNP differences between paired direct and 301
MGIT samples, counting only sites where both genotypes had high confidence 302
(difference between log likelihood of called genotype and of uncalled genotype 303 greater than 1), and neither site was called as heterozygous. 304 305
Samples were placed on the phylogenetic tree of 3480 samples from (1) were culture--confirmed M. tuberculosis ("culture--positive") and 2 were culture--387
negative. DNA was also extracted from 28 available corresponding MGIT 388
cultures. All direct samples were the remainder of specimens available after 389 processing by the routine laboratory, and therefore had variable volume (median 390 1.5 ml, IQR 0.5--3.1, range 0.25--15) and age (median 30 days from collection to 391 processing, IQR 15--45, range 0--67 preparation (Figure 1 ). 398 399
There was no evidence that DNA yield was affected (either in multivariable or 400 univariable models) by (1) and other bacterial reads, and 26% (10/39) contained >40% of reads from non--426 mycobacterial, non--NPF, bacteria (Figure 2a ). By comparison, MGIT culture 427 samples showed much less contamination, as expected. (Figure 2b) . 428 429
Recovery of M. tuberculosis genome 430 431 Figure 3a shows the distribution of the M. tuberculosis reference genome depth 432 of coverage across direct samples. Samples either have more than 10x depth and 433 recover more than 90% of the genome, or have <3x depth and recover less than 434
12% of the genome. The vertical dotted line delineates our threshold of 3x 435 coverage, below which resistance predictions were not made. Figure 3b shows 436 the amount of contamination (reads not mapping to M. tuberculosis) per sample. 437
Ten samples had <15% contaminant reads, although contamination levels 438 increased as high as 75% before the proportion of the M. tuberculosis genome 439 recovered started to drop. Low numbers of M. tuberculosis reads could also 440 reflect poor DNA quality from samples stored for long periods, as most of the 441 samples with <80% reference genome coverage (12/17, 71%) were more than 3 442 weeks old before extraction. 443 444 445
Concordance of results from direct and MGIT samples 446 447
We took a set of 68,695 high quality SNPs obtained from analysis of 3480 448
samples (1), and genotyped all samples at these positions (see Methods). This 449 allowed us to calculate a genetic distance between the 17 paired MGIT and direct 450 samples. The median (and modal) SNP difference was 1 (Figure 4a) , with one 451 outlier pair of samples that differed by 1106 SNPS, discussed below and all other 452 differences ≤22 SNPs. 453 454
We placed 17 paired direct and MGIT samples on the phylogeny from (1) (see 455 Methods). Our samples were distributed across global diversity (Figure 4b ; tree 456 thinned to aid visibility). For the pair with 1106 SNP differences, the MGIT 457 sample was placed very closely to 3 other pairs (0 SNP difference to one sample, 458
and 5 SNP differences to the others). Although this might result from different 459 strains being present within the host, a within--laboratory labelling error or 460 cross--contamination is also possible. 461 462 463
No evidence of higher diversity in direct samples 464 465
Comparing direct/MGIT pairs where both samples had at least 20x mean depth 466 of coverage on the M. tuberculosis reference, the median number of high 467 confidence (see Methods) heterozygous sites was 25 in both direct and MGIT 468
samples. There was no clear trend of greater genome--wide diversity in direct 469 samples ( Supplementary Figure 2) . 470 471
Detection of M. tuberculosis in culture positive/negative samples 472 473
All sequenced culture--positive (37/39) direct M. tuberculosis samples were 474 successfully identified by Mykrobe predictor to complex level (37/37) and 95% 475 to species level (35/37), including 13/37 (35%) where the mean depth of 476 coverage was <3. All MGIT cultures were identified as M. tuberculosis. We were 477 also able to identify M. tuberculosis in 2/2 direct samples with low AFB scores 478 (+1) and no growth in MGIT culture; this may represent dead bacilli from a 479 patient undergoing treatment. 480 481
Antibiotic resistance prediction 482 483
In total 168 predictions for first--line (n=96) and second--line (n=72) antibiotic 484 resistance were made for the 24/37 (65%) direct samples which had at least 3x 485 depth ( Supplementary Tables 4,5 ). For the 13/37 (35%) samples that had <3x 486 depth, no resistance predictions were made. This included 1/2 culture--negative 487 samples. 488 489 92/96 (96%) predictions for the first--line antibiotics were concordant with 490 reference laboratory DST. The four mismatches (three pyrazinamide mixed 491 genotypes with both R and S alleles present, and one rifampicin resistant 492 genotype with sensitive phenotype) were found across three samples, all from 493 the same patient (patient 2 in Supplementary Table 5 ) who had a variable 494 phenotype for rifampicin and pyrazinamide. The resistant genotype for 495
rifampicin was consistent across all three samples from this patient 496 (rpoB_I491F). There is evidence that this mutation causes resistance, but that the 497 phenotype is often reported as sensitive (27, 28, 1) . The mixed genotype for 498 pyrazinamide was again consistent with presence of both R and S alleles on 499 pncA_V7L across all three samples, whereas the phenotype varied. This mutation 500
is also known to confer resistance in samples reported as phenotypically 501
sensitive (1). Further, 1/3 samples from this patient (sample 602112, 502
Supplementary Table 4 ) contained two additional mutations conferring 503 resistance to isoniazid and pyrazinamide, katG_S315T and pncA_T135P 504 respectively, which were not detected in the previous or following sample. This 505 variation between same--patient samples taken over time may represent ongoing 506 evolution, changing population size, and within--patient diversity of M. 507 tuberculosis as previously demonstrated by Eldholm et al (29) . In addition to the 508 above, WGS provided 72 predictions for second--line antibiotics where DST was 509 not attempted. 510 511
The 13/37 samples that yielded insufficient WGS data for resistance prediction 512
had a higher proportion of other bacterial DNA (Figure 3b ; median 96%, IQR 38--513 70%, vs median 12%, IQR 0--67% , in those where resistance prediction was 514 possible, rank--sum p=0.01 Figure 3) , and that 532 >95% of the reference genome attained coverage >5x for all samples. In all cases 533
Mykrobe correctly identified the species/strain as M. bovis strain BCG (Table 2) . 534
Amplification with Phusion High--Fidelity master mix resulted in the highest yield 535 (760Mb, with 68x coverage of BCG In all 5 samples sequenced on R9 flowcells, data yield was highest at the start of 556 the run, with consistent yield profiles. For the Phusion/15% run we obtained 557 over 65% of the data in 8 hours, and 80% in 10 hours ( Supplementary Figure 4 ). 558
Thus we were able to detect BCG and predict the correct resistance with 10 559 hours of sequencing despite the high error rate (Supplementary Figure 5) This would give a turnaround time of 8 hours ( Figure 5 ). 577 578
We took our phylogenetic placement of the MiniSeq BCG data as truth, 4 SNPs 579 distant from a BCG sample on the predefined tree. By comparison, after 1 hour of 580 sequencing with R9.4, we were able to genotype 15592 of the 68695 SNPs, 581
placing the sample at the correct leaf of the tree, at an estimated distance of 25 582
SNPs. Thus, our genotyping on 1D nanopore reads had at most 29 errors out of 583 15592 SNPs --an error rate of 0.2%. 584 
